中国医学伦理学2025,Vol.38Issue(1):89-94,6.DOI:10.12026/j.issn.1001-8565.2025.01.13
生物医学新技术临床应用的伦理治理要点
Key points of ethical governance in the clinical application of new biomedical technology
摘要
Abstract
Given the current ethical issues such as unknown high risks in the clinical application of new biomedical technology,thus,medical institutions need to establish new technology management systems,including clarifying the concept,the assessment and admission mechanism,and ethical management systems of new technology.According to the direction of the development of new technology in the medical institution,the ethics review committee should also perfect the management system of ethics committees and the professional composition of ethics review committee members,improve the ability of ethics committee members to evaluate new biomedical technology,increase the assessment of ethical risks of new technology in the preliminary review stage,strengthen the requirements for emergency plan formulation,as well as set the frequency of the follow-up review based on the risk level of new technology.The ethics review committee should work together with the medical management department to formulate an ethical standardization training system for the clinical application of medical technology in the institution, and regularly conduct training for all staff, to promote medical workers' understanding of the management requirements of biomedical technologies. Different types of new biomedical technology have different ethical risks. Therefore, the medical management departments and ethics review committees of medical institutions should formulate specific management rules based on the characteristics of new technology types. However, it should be noted that when new biomedical technology generally is first introduced into clinical practice, there are often issues regarding fairness and justice in the use of the technology.关键词
生物医学新技术/临床应用/患者保护/伦理治理Key words
new biomedical technology/clinical application/patient protection/ethical governance分类
医药卫生引用本文复制引用
袁平,李红娟,李晓京,张秀英,张琼阁,王宏宇..生物医学新技术临床应用的伦理治理要点[J].中国医学伦理学,2025,38(1):89-94,6.基金项目
北京市医学伦理管理质量提高项目"医疗集团伦理审查模式探索"(京伦2024-12) (京伦2024-12)